Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in venous thromboembolism

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 5, 2014, Pages 416-421

  Kwon, Aerin ^a   Jo, Sang Ho ^a   Jo, Yun A ^a   Park, Ji Young ^a   Kim, Miyoung ^a   Kang, Hee Jung ^a   Kim, Han Sung ^a   Cho, Hyoun Chan ^a   Lee, Young Kyung ^a  

^a Hallym University   (South Korea)

Author keywords

Blood coagulation; Genetic; Polymorphism; Single nucleotide; Thromboplastin; Tissue factor pathway inhibitor; Venous thromboembolism

Indexed keywords

D DIMER; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KOREAN (PEOPLE); MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; VENOUS THROMBOEMBOLISM; BLOOD; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; HUMANS; LIPOPROTEINS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; VENOUS THROMBOEMBOLISM;

EID: 84904984464     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000063     Document Type: Article

References (28)

1. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007; 44: 62-69. (Pubitemid 46553809)
2. Malone PC, Agutter PS. The aetiology of deep venous thrombosis. QJ Med 2006; 99: 581-593. (Pubitemid 44540534)
3. Blann AD, Lip GY. Venous thromboembolism. BMJ 2006; 332: 215-219. (Pubitemid 43171703)
4. Lijfering WM, Rosendaal FR, Cannegieter SC. Risk factors for venous thrombosis: current understanding from an epidemiological point of view. Br J Haematol 2010; 149: 824-833.
5. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-I8. (Pubitemid 41289265)
6. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107: I9-I16. (Pubitemid 41289266)
7. Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008; 112: 19-27.
8. Maroney SA, Mast AE. Expression of tissue factor pathway inhibitor by endothelial cells and platelets. Transfus Apher Sci 2008; 38: 9-14.
9. Manly DA, Boles J, Mackman N. Role of tissue factor in venous thrombosis. Annu Rev Physiol 2011; 73: 515-525.
10. Owens III AP, Mackman N. Tissue factor and thrombosis: the clot starts here. Thromb Haemost 2010; 104: 432-439.
11. Sidelmann JJ, Bladbjerg E, Gram J, Münster AB, Jespersen J. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis. Blood Coagul Fibrinolysis 2008; 19: 405-409.
12. Kasthuri RS, Glover SL, Boles J, Mackman N. Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays. Semin Thromb Hemost 2010; 36: 764-771.
13. Dahm A, van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood 2003; 101: 4387-4392. (Pubitemid 36857803)
14. Marsik C, Endler G, Halama T, Schlifke I, Mustafa S, Hysjulien JL, et al. Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytes. J Thromb Haemost 2006; 4: 745-749.
15. Arnaud E, Barbalat V, Nicaud V, Cambien F, Evans A, Morrison C, et al. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Arterioscler Thromb Vasc Biol 2000; 20: 892-898. (Pubitemid 30151708)
16. Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sanset PM. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy. Blood Coagul Fibrinolysis 2010; 21: 516-521.
17. Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, et al. Functional characterization of polymorphisms in the human TFPI gene. Biochem Biophys Res Commun 2010; 397: 106-111.
18. Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, et al. The -33T!C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb Haemost 2002; 88: 195-199. (Pubitemid 34873697)
19. Yoon SZ, Kim CS, Lee YH, Heo WS, Kim SH, Lee J, et al. Association of tissue factor polymorphism with fibrinolysis and excessive bleeding after open heart surgery: a preliminary report. Korean J Anesthesiol 2007; 53: 720-726.
20. Dai XL, Hong JM, Oh B, Cho YS, Lee J, Park EK, et al. Association analysis of tissue factor pathway inhibitor polymorphisms and haplotypes with osteonecrosis of the femoral head in the Korean population. Mol Cells 2008; 26: 490-495.
21. Mälarstig A, Tenno T, Johnston N, Lagerqvist B, Axelsson T, Syvänen A, et al. Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 2005; 25: 2667-2672. (Pubitemid 43732295)
22. Opstad TB, Pettersen AÅ, Weiss T, Arnesen H, Seljeflot I. Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb J 2010; 8: 7.
23. Ishikawa J, Okada H, Kato H, Takeshita S, Honda S, Kawasaki T, et al. Association of Asn221Ser mutation in tissue factor pathway inhibitor-(with plasma total tissue factor pathway inhibitor level. Blood Coagul Fibrinolysis 2009; 20: 22-26.
24. Kamikura Y, Wada H, Nobori T, Kobayashi T, Sase T, Nishikawa M, et al. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism. Thromb Res 2005; 116: 307-312. (Pubitemid 40994913)
25. Kim HK, Song KS, Park YS, Yun Y, Shim WH. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease. Cardiology 2000; 93: 31-36. (Pubitemid 30436408)
26. Amini-Nekoo A, Futers TS, Moia M, Mannucci PM, Grant PJ, Ariëns RA. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br J Haematol 2001; 113: 537-543. (Pubitemid 32523166)
27. Amini-Nekoo A, Iles D. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter. Thromb Res 2008; 121: 813-819. (Pubitemid 351491295)
28. Terry CM, Kling SJ, Cheang KI, Hoidal JR, Rodgers GM. Polymorphisms in the 5′-UTR of the tissue factor gene are associated with altered expression in human endothelial cells. J Thromb Haemost 2004; 2: 1351-1358. (Pubitemid 40186132)